Loewen Andrea

CIK 00015911002 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001591100

Recent Transactions

18 trades

Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−35,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−11,250→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−9,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−28,416→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−47,738→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-14$172.03/sh−3,175→ 28,416 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-16$81.02/sh−313→ 31,591 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-15$84.71/sh−103→ 31,904 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-12$86.26/sh−6,750→ 32,007 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$27.32/sh+15,000→ 57,793 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$84.44/sh−1,200→ 38,757 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-03-07−15,000→ 35,000 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$83.36/sh−17,836→ 39,957 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-03$87.73/sh−1,601→ 42,793 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-02$90.61/sh−218→ 44,394 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-01-03+11,756→ 44,612 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-01-03+47,738→ 47,738 total
Award
IMMUNIC, INC.$IMUX
Stock Option (right to buy)
2016-05-13+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O VITAL THERAPIES, INC. 15010 AVENUE OF SCIENCE, SUITE 200

SAN DIEGO, CA, 92128

View on SEC.gov